360 Stem Cell & Regenerative Medicine Newsletter- October 15, 2014

 weSRCH's Best of the Internet Award

360 Stem Cell & Regenerative Medicine Newsletter - Oct 15, 2014

Featured video from WSJ: Treating Eye Diseases With Stem Cells
Treating AMD & Stargardts disease
Scientists have found that cells from human embryos can improve vision. This WSJ video explains the science in simple terms. There is a short advertisement preceding the broadcast.
New Scientist: Human embryonic stem cells improve vision enough for horse riding
A trial in 18 people with degenerative eye conditions is being hailed as the most promising yet for a treatment based on human embryonic stem cells. One of the patients even regained enough vision to ride his horse. In a study published in Lancet, scientists led by Dr. Robert Lanza, CSO at Advanced Cell Technology, provided the first evidence that hESC’s can be a safe and effective source of therapies for age-related macular degeneration and Stargardt’s macular dystrophy.
The Boston Globe: Stem cell research offers hope on type 1 diabetes
In a paper published in the journal Cell, Harvard Stem Cell Institute researcher Doug Melton and his collaborators reported “a step-by-step procedure that starts with stem cells and results in hundreds of millions of the precious pancreatic cells that secrete the hormone insulin, keeping blood sugar levels in balance. It is the lack of insulin produced by those cells, called beta cells, that lies at the root of type 1 diabetes. Ultimately, the hope is those cells could be transplanted into diabetes patients and allow them to create insulin naturally, creating a paradigm shift in treating a disease currently kept in check by insulin injections.”

Editor’s comment: The results reported by Dr. Lanza and Dr. Melton validate the efforts by the stem cell advocacy community that labored to protect this valuable research from unreasonable government restrictions. We must use all the cells in our toolkit to attack chronic disease and alleviate the consequential vast human suffering.

Marius Wernig receives New York Stem Cell Foundation's prestigious Robertson Stem Cell Prize
Marius Wernig, PhD, Associate Professor in the Institute for Stem Cell Biology and Regenerative Medicine and the Department of Pathology at Stanford University School of Medicine, is the 2014 recipient of the NYSCF – Robertson Stem Cell Prize of $200,000. The prize is for extraordinary achievements in translational stem cell research by a young scientist. Dr. Wernig and his team discovered that human skin cells can be converted directly into functional neurons, termed induced neuronal (iN) cells, in a period of four to five weeks with the addition of just four proteins. "Dr. Wernig's groundbreaking research has the potential to accelerate all research on devastating neurodegenerative diseases," said Susan L. Solomon, CEO and Co-founder of NYSCF. "His work can impact and accelerate research on multiple sclerosis, Alzheimer's disease, and autism among many other conditions."
The New York Stem Cell Foundation announces $9 million to 6 new NYSCF -- Robertson investigators
The New York Stem Cell Foundation (NYSCF) named six of the most promising scientists as its 2014 NYSCF – Robertson Investigators. Each Investigator will receive a $1.5 million award, which will be disbursed over the next five years. The awardees are: Valentina Greco, PhD (Yale); Jennifer E. Phillips-Cremins, PhD, (Penn); Feng Zhang, PhD, (MIT); Edward Chang, MD, (University of California, San Francisco); Lisa Giocomo, PhD, (Stanford University School of Medicine) and Kay M. Tye, PhD (MIT).
Stem Cell Research
Cesca Therapeutics to provide storage, processing and consumable platform for New York Upstate Cord Blood Bank
“Cesca Therapeutics, an autologous cell-based regenerative medicine company, secured a contract to provide its cell storage, processing and consumables platform to Upstate Medical University's, Upstate Cord Blood Bank, one of two public blood cord banks in New York State and one of 27 total public cord blood banks in the United States. Upstate Cord Blood Bank, the newly created $15 million health sciences center in Syracuse, New York, will collect, process and store umbilical cord blood donated by families throughout Central and Northern New York. Cord blood will be banked and used by those in need of life-saving medical treatments and for medical research.”
Science AAAS: Final chapter in Italian stem cell controversy?
A panel of experts appointed by the Italian Ministry of Health concluded that the trial of the so-called Stamina method should not move forward. Science Insider provides insight into this latest development.
Daily Mail: Surgeon who made history with womb transplant first now aims to grow one from SCRATCH within a decade
The Mail Online came up with the headline of the month. What are the ramifications of growing a womb from stem cells?
San Antonio based StemBioSys secures new research space at BioBridge Global
According to the San Antonio Business Journal, BioBridge Global, a nonprofit organization involved in a number of areas including regenerative medicine, blood banking and biologic testing, has constructed lab space that will be used by StemBioSys, a development-stage company engaged in stem cell and regenerative medicine research. StemBioSys will conduct research and product development activities in the new laboratory. StemBioSys had received a grant of $200,000 from the San Antonio Economic Development Foundation, evidencing the City’s commitment to expand regenerative medicine industry growth in the region.
Palm Beach Post: University of Miami working on new breast cancer treatment
Dr. Tan Ince, a pathology professor at the University of Miami and accomplished breast cancer researcher, is working on a new personalized multi-hormone treatment protocol for breast cancer patients.
Editor’s invitation: This newsletter is published by the nonprofit, Genetics Policy Institute (GPI). We also produce the annual World Stem Cell Summit and RegMed Capital Conference. These co-located and combined meetings will take place in San Antonio, Texas, December 3-5. This year there will be a free public day on December 2. I ask that all readers of this newsletter to seriously consider joining the meeting that unites the huge stem cell and regenerative medicine communities around the world. Regenerative medicine is the future of medicine and the 10th anniversary Summit is designed to the one place to secure a 360-degree view of this burgeoning field. Think about the Summit as a partnering forum that offers you the best opportunity to interact with the leading experts from around the world. You will be at the ground floor of something that might be as profound to humankind as the launch of the Internet, invention of the internal combustion engine and the development of antibiotics and vaccines. In a nutshell, it’s very new and important to your future.

360 Newsletter Editor

Bernard Siegel
Executive Director
Genetics Policy Institute

Stem Cells and the Transformative Power of Hope-a TEDx talk by Bernard Siegel, Editor of 360 Newsletter
Domain: Medical
Category: Biology

Recent Newsletters

12 March, 2019
10 October, 2018
15 February, 2018